These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34382143)

  • 1. Enhancement of Docetaxel Absorption Using Ritonavir in an Oral Milk-Based Formulation.
    Soulele K; Karampelas T; Tamvakopoulos C; Macheras P
    Pharm Res; 2021 Aug; 38(8):1419-1428. PubMed ID: 34382143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development.
    Yu H; Janssen JM; Sawicki E; van Hasselt JGC; de Weger VA; Nuijen B; Schellens JHM; Beijnen JH; Huitema ADR
    J Clin Pharmacol; 2020 Mar; 60(3):340-350. PubMed ID: 31595980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir.
    Yu H; Janssen JM; de Weger VA; Nuijen B; Stuurman RE; Marchetti S; Schellens JHM; Beijnen JH; Dorlo TPC; Huitema ADR
    Invest New Drugs; 2020 Oct; 38(5):1526-1532. PubMed ID: 32306204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours.
    Vermunt MAC; van der Heijden LT; Hendrikx JJMA; Schinkel AH; de Weger VA; van der Putten E; van Triest B; Bergman AM; Beijnen JH
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):855-869. PubMed ID: 33744986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir.
    de Weger VA; Stuurman FE; Koolen SLW; Moes JJ; Hendrikx JJMA; Sawicki E; Thijssen B; Keessen M; Rosing H; Mergui-Roelvink M; Huitema ADR; Nuijen B; Beijnen JH; Schellens JHM; Marchetti S
    Clin Cancer Res; 2019 Sep; 25(18):5466-5474. PubMed ID: 31217201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.
    Koolen SL; Oostendorp RL; Beijnen JH; Schellens JH; Huitema AD
    Br J Clin Pharmacol; 2010 May; 69(5):465-74. PubMed ID: 20573082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.
    Vermunt MAC; de Weger VA; Janssen JM; Lopez-Yurda MI; Keessen M; Thijssen B; Rosing H; Huitema ADR; Beijnen JH; Marchetti S
    Drugs R D; 2021 Mar; 21(1):103-111. PubMed ID: 33464545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment.
    Loos NHC; Bui V; de Jong DH; Lebre MC; Rosing H; Beijnen JH; Schinkel AH
    Cancer Chemother Pharmacol; 2024 Jul; 94(1):79-87. PubMed ID: 38456955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.
    Miller DA; Keen JM; Brough C; Ellenberger DJ; Cisneros M; Williams RO; McGinity JW
    J Pharm Pharmacol; 2016 May; 68(5):678-91. PubMed ID: 26454138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
    Moes JJ; Koolen SL; Huitema AD; Schellens JH; Beijnen JH; Nuijen B
    Int J Pharm; 2011 Nov; 420(2):244-50. PubMed ID: 21907780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Deoxycholate-Modified Docetaxel-Cimetidine Complex Chitosan Nanoparticles to Improve Oral Bioavailability.
    Xu Y; Fang T; Yang Y; Sun L; Shen Q
    AAPS PharmSciTech; 2019 Sep; 20(7):302. PubMed ID: 31489504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of ritonavir strongly enhances the apparent oral bioavailability of docetaxel in patients with solid tumors.
    Oostendorp RL; Huitema A; Rosing H; Jansen RS; Ter Heine R; Keessen M; Beijnen JH; Schellens JH
    Clin Cancer Res; 2009 Jun; 15(12):4228-33. PubMed ID: 19509162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet.
    Moes JJ; Stuurman FE; Hendrikx JJ; Marchetti S; Huitema AD; Beijnen JH; Schellens JH; Nuijen B
    Drug Deliv Transl Res; 2013 Jun; 3(3):243-51. PubMed ID: 25788133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.
    Bohr A; Nascimento TL; Harmankaya N; Weisser JJ; Wang Y; Grohganz H; Rades T; Löbmann K
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30642009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
    Bardelmeijer HA; Ouwehand M; Buckle T; Huisman MT; Schellens JH; Beijnen JH; van Tellingen O
    Cancer Res; 2002 Nov; 62(21):6158-64. PubMed ID: 12414642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation.
    Hendrikx JJ; Lagas JS; Wagenaar E; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Br J Cancer; 2014 May; 110(11):2669-76. PubMed ID: 24781280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ritonavir paediatric powder formulation is bioequivalent to ritonavir oral solution with a similar food effect.
    Salem AH; Chiu YL; Valdes JM; Nilius AM; Klein CE
    Antivir Ther; 2015; 20(4):425-32. PubMed ID: 25573904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.
    Dhore PW; Dave VS; Saoji SD; Bobde YS; Mack C; Raut NA
    Pharm Dev Technol; 2017 Feb; 22(1):90-102. PubMed ID: 27291246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.